Close
Nordic 9Nordic 9

Esperante Ventures (investor - Venture Capital)

Netherlands esperanteventures.com
See something wrong or missing? Let us know
Offices:Amsterdam

Esperante Ventures is a venture investment company controlled by C&P Group Holdings, a privately controlled life science interests group from the Netherlands.

Average round investment:2.62M USD
Average number per year:1.0
Distribution: 2024 (1)2022 (1)
Portfolio companies: United Kingdom AMLo Biosciences
Mostly invests in: United Kingdom United Kingdom (2) Biotech (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Esperante Ventures

Name Criteria
United Kingdom Wealth Club
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Wren Capital
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Orange Light Ventures
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom James Dacombe
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Social Impact Capital
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United Kingdom AI Seed
82%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
United Kingdom Conduit Ventures
82%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom London Co-Investment Fund
82%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.4
  • Active last 12 months: Yes
Italy Pi Campus
82%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United Kingdom Calculus Capital
81%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Top